Longitudinal Assessment of Colonic Tumor Fate in Mice by Computed Tomography and Optical Colonoscopy
Rationale and Objectives
The purpose of this study was to evaluate the relative merits of micro-computed tomograph colonography (mCTC) and optical colonoscopy (OC) for longitudinal studies of colonic tumors in mice.
Materials and Methods
Colonic tumors in mice carrying the Min allele of Apc were followed over several weeks using mCTC and OC. A total of 146 colonic tumors were monitored: 62 in 32 untreated Min mice, 53 in 43 Min mice treated with 5-fluorouracil (5-FU), and 31 in 17 Min mice treated with piroxicam.
Results
Colonic tumors in Min mice had three different spontaneous fates: 29 grew, 24 remained static, and 9 regressed. Treating Min mice with 5-FU increased the percentage of regressing tumors from 15% to 58%. The response was dependent in part on the initial size of the tumor. By contrast, treating Min mice with piroxicam did not alter colonic tumor fate.
Conclusions
mCTC and OC can be used to determine the spontaneous fates of colonic tumors in mice and to document their individual responses to treatment. The ability to follow individually annotated colonic tumors reduces the number of mice needed for testing.
Key Words: Mouse models of human colorectal cancer, microCT colonography, optical colonoscopy, longitudinal studies, tumor fate mapping
To access this article, please choose from the options below
Supported by funds to Jamey Weichert from the University of Wisconsin Comprehensive Cancer Center, grants R37CA63677and U01CA84227 to William F. Dove from the National Cancer Institute, grant R01 CA64364 to Michael A. Newton from the National Cancer Institute, and grant U19CA113297–03 to Ben Shen from the National Cancer Institute NCDDG Program.
PII: S1076-6332(09)00427-9
doi:10.1016/j.acra.2009.07.023
© 2009 AUR. Published by Elsevier Inc. All rights reserved.
